A detailed history of China Universal Asset Management Co., Ltd. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 54,335 shares of PACB stock, worth $105,953. This represents 0.01% of its overall portfolio holdings.

Number of Shares
54,335
Previous 33,918 60.2%
Holding current value
$105,953
Previous $46,000 100.0%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$1.2 - $2.17 $24,500 - $44,304
20,417 Added 60.2%
54,335 $92,000
Q2 2024

Jul 19, 2024

SELL
$1.36 - $3.65 $26,560 - $71,284
-19,530 Reduced 36.54%
33,918 $46,000
Q1 2024

Apr 29, 2024

BUY
$3.52 - $9.59 $72,487 - $197,486
20,593 Added 62.68%
53,448 $200,000
Q4 2023

May 21, 2024

SELL
$5.97 - $10.36 $122,940 - $213,343
-20,593 Reduced 38.53%
32,855 $322,000
Q4 2023

Jan 23, 2024

BUY
$5.97 - $10.36 $75,389 - $130,826
12,628 Added 62.43%
32,855 $322,000
Q3 2023

May 21, 2024

BUY
$8.23 - $13.93 $25,916 - $43,865
3,149 Added 18.44%
20,227 $168,000
Q3 2023

Oct 30, 2023

BUY
$8.23 - $13.93 $25,916 - $43,865
3,149 Added 18.44%
20,227 $169,000
Q2 2023

May 21, 2024

SELL
$9.97 - $14.05 $727 - $1,025
-73 Reduced 0.43%
17,078 $227,000
Q2 2023

Jul 27, 2023

SELL
$9.97 - $14.05 $727 - $1,025
-73 Reduced 0.43%
17,078 $227,000
Q1 2023

May 21, 2024

BUY
$7.94 - $12.02 $8,344 - $12,633
1,051 Added 6.53%
17,151 $198,000
Q1 2023

Apr 27, 2023

BUY
$7.94 - $12.02 $8,344 - $12,633
1,051 Added 6.53%
17,151 $199,000
Q4 2022

May 21, 2024

SELL
$5.67 - $11.2 $211,763 - $418,297
-37,348 Reduced 69.88%
16,100 $131,000
Q4 2022

Jan 31, 2023

BUY
$5.67 - $11.2 $79,351 - $156,744
13,995 Added 664.85%
16,100 $132,000
Q3 2022

Oct 21, 2022

BUY
$3.93 - $8.57 $8,272 - $18,039
2,105 New
2,105 $12,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.